Bardy Diagnostics Annual Revenue, Number of Employees, Growth and Funding

Claim your profile


Seattle, WA USA
Total Funding:$35M
Industry:Medical Equip
Lead Investor(s):SV Health Investors, Health Enterprise Partners
Claim your profile

City Ranking

Industry Ranking

State Ranking

Growjo 10k Ranking

Estimated Revenue & Financials

  • Bardy Diagnostics's estimated annual revenue is currently $24.8M per year.
  • Bardy Diagnostics received $Undisclosed in venture funding in July 2018.
  • Bardy Diagnostics's estimated revenue per employee is $251,000
  • Bardy Diagnostics's total funding is $35M.

Employee Data

  • Bardy Diagnostics has 99 Employees.
  • Bardy Diagnostics grew their employee count by 36% last year.
  • Bardy Diagnostics currently has 2 job openings.

Executive Contacts

Liz MynhierSr. Director Of Clinical Services & Customer Experience
James LandisSales Director
Ken NelsonChief Commercial Officer
Lita MonaghanProgram Manager
Adam KirchgessnerRegional Sales Director
Brit BairdSenior Director Of Regulatory Affairs And Quality Assurance
Benjamin HornseyRegulatory Affairs Manager
Jonathan WuDirector Of Strategic Marketing
Mia BrewerClinical Field Manager (East Coast)
Gust BardyChairman/Chief Executive Officer & Chief Medical Officer

Bardy Diagnostics, Inc. ( has created a new, state-of-the-art heart monitor known as Carnation Ambulatory Monitor (CAM) that can be worn comfortably and discreetly for up to 7 days. Unlike many other heart monitors, CAM can be worn during exercise or while showering. Its unique, narrow, hourglass shape makes it especially advantageous for the female anatomy. Bardy Dx was founded to address the long-standing complaint in cardiac arrhythmia monitoring that traditional monitors were large, bulky, uncomfortable, and typically recorded noisy QRS signals. Our goal: to completely redesign an arrhythmia monitor with optimal signal detection, comfort, and ease of use. CAM is the first P-wave centric ECG monitor - a single-patient use monitor that records continuously for up to 7 days. This focus on the P-wave is a major new tool for cardiologists and cardiac rhythm specialists for accurately diagnosing arrhythmias.



Number of Employees


Revenue (est)


Current Jobs


Employee Growth %


Total Funding







NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
Magnolia Medica...
Uptake Medical
Solta Medical
Simulab Corpora...
Summit Surgical
Young Dental Ca...
MicroSurgical T...
Kestra Medical ...

Bardy Diagnostics News

09/07/2019 - Bardy Diagnostics™ Receives FDA 510(k) Clearance for 14 ...

SEATTLE, Sept. 6, 2019 /PRNewswire/ -- Bardy Diagnostics, Inc. Inc., ("BardyDx"), a leading provider of ambulatory cardiac monitoring ...

09/08/2019 - FDA clears 14-Day version of ambulatory cardiac patch ...

The clearance was received by Bardy Diagnostics, Inc., (“BardyDx”), a leading provider of ambulatory cardiac monitoring technologies and custom data ...

08/15/2019 - Bardy Diagnostics Selected for HealthTech Arkansas ...

August 15, 2019 — Bardy Diagnostics Inc. announced that HealthTech Arkansas, a healthcare accelerator and investment fund that connects early-stage ...

Bardy Diagnostics Funding

DateAmountRoundLead InvestorsReference
2018-07-19$UndisclosedUndisclosedSV Health InvestorsArticle

Bardy Diagnostics Executive Hires

2018-04-03Ken NelsonChief Commercial OfficerArticle